ENDRA Life Sciences Inc
NASDAQ:NDRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
ENDRA Life Sciences Inc (NDRA) under the Base Case is 4.8437 USD per share.
Compared with the current market price of 4.7688 USD, the stock appears
Undervalued by 2% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What ENDRA Life Sciences Does
ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company is headquartered in Ann Arbor, Michigan and currently employs 11 full-time employees. The company went IPO on 2017-06-28. TAEUS is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical…
- Headquarters
- United States of America US
- Employees
- 11
- IPO date
- Jun 28, 2017
Revenue & Expenses Breakdown
ENDRA Life Sciences Inc
Earnings Waterfall
ENDRA Life Sciences Inc
What is the Intrinsic Value of one NDRA stock?
The intrinsic value for ENDRA Life Sciences Inc (NDRA) under the Base Case is 4.8437 USD.
Is NDRA stock undervalued or overvalued?
Compared with the current market price of 4.7688 USD, the stock appears Undervalued by 2% .
